DE602005010694D1 - Piperazinderivate von alkyloxindolen - Google Patents
Piperazinderivate von alkyloxindolenInfo
- Publication number
- DE602005010694D1 DE602005010694D1 DE602005010694T DE602005010694T DE602005010694D1 DE 602005010694 D1 DE602005010694 D1 DE 602005010694D1 DE 602005010694 T DE602005010694 T DE 602005010694T DE 602005010694 T DE602005010694 T DE 602005010694T DE 602005010694 D1 DE602005010694 D1 DE 602005010694D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyloxindolses
- piperazine derivatives
- derivatives
- new
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000005625 indol-2-ones Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400954A HU0400954D0 (en) | 2004-05-11 | 2004-05-11 | Piperazine derivatives of alkyl oxindoles |
| HU0500461A HUP0500461A3 (en) | 2005-05-05 | 2005-05-05 | Pyperazine derivatives of alkyl-oxindoles |
| PCT/HU2005/000048 WO2005108363A1 (en) | 2004-05-11 | 2005-05-10 | Piperazine derivatives of alkyl oxindoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602005010694D1 true DE602005010694D1 (de) | 2008-12-11 |
Family
ID=89985994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005010694T Active DE602005010694D1 (de) | 2004-05-11 | 2005-05-10 | Piperazinderivate von alkyloxindolen |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070219209A1 (de) |
| EP (1) | EP1751106B1 (de) |
| JP (1) | JP2007537226A (de) |
| KR (1) | KR20070011551A (de) |
| AT (1) | ATE412634T1 (de) |
| AU (1) | AU2005240842B2 (de) |
| BG (1) | BG109768A (de) |
| CA (1) | CA2564009A1 (de) |
| CZ (1) | CZ2006778A3 (de) |
| DE (1) | DE602005010694D1 (de) |
| DK (1) | DK1751106T3 (de) |
| EA (1) | EA011280B1 (de) |
| ES (1) | ES2317241T3 (de) |
| HR (2) | HRP20060401A2 (de) |
| IL (1) | IL178759A0 (de) |
| MX (1) | MXPA06013064A (de) |
| NO (1) | NO20065697L (de) |
| NZ (1) | NZ551542A (de) |
| PL (1) | PL1751106T3 (de) |
| PT (1) | PT1751106E (de) |
| RS (1) | RS20060620A (de) |
| SI (1) | SI1751106T1 (de) |
| SK (1) | SK51112006A3 (de) |
| WO (1) | WO2005108363A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS20060623A (en) * | 2004-05-11 | 2008-09-29 | Egis Gyogyszergyar Nyrt., | New piperazine derivatives of dialkyl oxindoles |
| CN106243088B (zh) | 2015-06-03 | 2019-01-04 | 广东东阳光药业有限公司 | 取代的哌嗪化合物及其使用方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4452808A (en) * | 1982-12-07 | 1984-06-05 | Smithkline Beckman Corporation | 4-Aminoalkyl-2(3H)-indolones |
| MX173362B (es) * | 1987-03-02 | 1994-02-23 | Pfizer | Compuestos de piperazinil heterociclicos y procedimiento para su preparacion |
| FR2635104B1 (fr) * | 1988-08-03 | 1992-04-30 | Synthelabo | Derives d'indolone, leur preparation et leur application en therapeutique |
| GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
| WO1998008816A1 (fr) * | 1996-08-26 | 1998-03-05 | Meiji Seika Kaisha, Ltd. | Derives d'indoxyle et psychotropes |
-
2005
- 2005-05-10 WO PCT/HU2005/000048 patent/WO2005108363A1/en active Application Filing
- 2005-05-10 DE DE602005010694T patent/DE602005010694D1/de active Active
- 2005-05-10 EP EP05745442A patent/EP1751106B1/de active Active
- 2005-05-10 AT AT05745442T patent/ATE412634T1/de active
- 2005-05-10 AU AU2005240842A patent/AU2005240842B2/en not_active Ceased
- 2005-05-10 ES ES05745442T patent/ES2317241T3/es active Active
- 2005-05-10 SI SI200530563T patent/SI1751106T1/sl unknown
- 2005-05-10 JP JP2007512356A patent/JP2007537226A/ja active Pending
- 2005-05-10 CZ CZ20060778A patent/CZ2006778A3/cs unknown
- 2005-05-10 PL PL05745442T patent/PL1751106T3/pl unknown
- 2005-05-10 NZ NZ551542A patent/NZ551542A/en unknown
- 2005-05-10 DK DK05745442T patent/DK1751106T3/da active
- 2005-05-10 RS RSP-2006/0620A patent/RS20060620A/sr unknown
- 2005-05-10 CA CA002564009A patent/CA2564009A1/en not_active Abandoned
- 2005-05-10 PT PT05745442T patent/PT1751106E/pt unknown
- 2005-05-10 KR KR1020067025135A patent/KR20070011551A/ko not_active Application Discontinuation
- 2005-05-10 SK SK5111-2006A patent/SK51112006A3/sk not_active Application Discontinuation
- 2005-05-10 MX MXPA06013064A patent/MXPA06013064A/es active IP Right Grant
- 2005-05-10 US US11/596,466 patent/US20070219209A1/en not_active Abandoned
- 2005-05-10 EA EA200602080A patent/EA011280B1/ru not_active IP Right Cessation
-
2006
- 2006-10-19 IL IL178759A patent/IL178759A0/en unknown
- 2006-11-20 HR HR20060401A patent/HRP20060401A2/xx not_active Application Discontinuation
- 2006-12-11 BG BG109768A patent/BG109768A/bg unknown
- 2006-12-11 NO NO20065697A patent/NO20065697L/no not_active Application Discontinuation
-
2009
- 2009-01-29 HR HR20090054T patent/HRP20090054T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2564009A1 (en) | 2005-11-17 |
| ES2317241T3 (es) | 2009-04-16 |
| EP1751106A1 (de) | 2007-02-14 |
| EP1751106B1 (de) | 2008-10-29 |
| KR20070011551A (ko) | 2007-01-24 |
| EA011280B1 (ru) | 2009-02-27 |
| JP2007537226A (ja) | 2007-12-20 |
| BG109768A (bg) | 2008-03-31 |
| PT1751106E (pt) | 2009-02-10 |
| AU2005240842B2 (en) | 2011-10-06 |
| CZ2006778A3 (cs) | 2007-03-07 |
| HRP20090054T3 (en) | 2009-03-31 |
| EA200602080A1 (ru) | 2007-04-27 |
| DK1751106T3 (da) | 2009-03-09 |
| HRP20060401A2 (en) | 2007-03-31 |
| AU2005240842A1 (en) | 2005-11-17 |
| SI1751106T1 (sl) | 2009-06-30 |
| NO20065697L (no) | 2007-02-02 |
| WO2005108363A1 (en) | 2005-11-17 |
| NZ551542A (en) | 2010-06-25 |
| PL1751106T3 (pl) | 2009-07-31 |
| RS20060620A (en) | 2008-09-29 |
| SK51112006A3 (sk) | 2007-05-03 |
| IL178759A0 (en) | 2007-02-11 |
| MXPA06013064A (es) | 2007-04-27 |
| US20070219209A1 (en) | 2007-09-20 |
| ATE412634T1 (de) | 2008-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| NO20056130L (no) | Nye substituerte 3-svovelindoler | |
| SE0203713D0 (sv) | Novel compounds | |
| EA201100749A1 (ru) | Производные пиридина и пиримидина в качестве ингибиторов фосфодиэстеразы 10 | |
| CY1111206T1 (el) | Βενζοθειοφαινια υποκατεστημενα με πιπεραζινη για την αγωγη διανοητικων διαταραχων | |
| EA200600048A1 (ru) | Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором | |
| SE0201635D0 (sv) | Novel compounds | |
| EA200700909A1 (ru) | Азаиндолкарбоксамиды | |
| NO20082136L (no) | 1,5-substituerte indol-2-yl-amidderivater | |
| ATE467632T1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
| NO20065768L (no) | Karbonsamid-opioidforbindelser | |
| ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| EA200602081A1 (ru) | Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7 | |
| ATE412634T1 (de) | Piperazinderivate von alkyloxindolen | |
| EA200602083A1 (ru) | Новые пиперазиновые производные диалкилоксиндолов | |
| EA200602084A1 (ru) | Пиперазиновые производные алкилоксиндолов | |
| ATE423772T1 (de) | Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin | |
| IL179030A0 (en) | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders | |
| ECSP066555A (es) | Derivados de morfolina como inhibidores de la reabsorcion de norepinefrina | |
| UA86809C2 (en) | Piperazine derivatives of alkyl oxindoles | |
| SE0301795D0 (sv) | New use I |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |